Stifel's commentary also mentioned that C.H. Robinson has been considered a "show-me story," indicating that the market has been waiting for proof of the company's performance and strategy ...
UBS analyst Timothy Arcuri adjusted the price target on Teradyne (NASDAQ:TER) shares to $155.00, down from the previous $160.00, while reiterating a Buy rating on the stock. The adjustment comes as ...